Riskpilot← Back to searchSign inGet full accessAni Labsystems Ltd. Oy
OYIn liquidationY-tunnus 2652507-5Tiilitie 3Other human health activities n.e.c. · NACE 8699Est. 2014— employees
Revenue 2023
EUR 0
EBITDA margin
—
Equity ratio
27.2%
Financial strength
Net profit 2023
EUR 0
+100% vs 2022
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | +100% |
| Total assets | EUR 15K | -4% |
| Equity | EUR 4K | -13% |
| Employees | — | — |
Legal name
Ani Labsystems Ltd. Oy
Y-tunnus number
2652507-5
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
4. marraskuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-03-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimialana on joko suoraan tai tytäryhtiöidensä välityksellä harjoittaa diagnostiikkatuotteiden kehittämistä, valmistamista, myyntiä ja markkinointia sekä muita niihin liittyviä toimintoja. Yhtiö voi myös omistaa ja hallita kiinteistöjä ja arvopapereita sekä tarjota hallinnollisia, rahoitus- ja muita palveluita muille sen kanssa samaan konserniin kuuluville yhtiöille.
Address
Tiilitie 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | −0 | −0 |
| EBITDA | −0 | −0 | −0 | 0 |
| Depreciation & amort. | — | — | −0 | −0 |
| EBIT | −0 | −0 | −0 | 0 |
| Net financials | — | — | 0 | 0 |
| Profit before tax | −0 | −0 | −0 | 0 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −0 | −0 | −0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 16 | 16 | 16 | 15 |
| Equity | 5 | 5 | 5 | 4 |
| Long-term debt | — | — | 0 | 0 |
| Short-term debt | 11 | 11 | 11 | 11 |
| Total debt | 11 | 11 | 11 | 11 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202023
Equity ratio
27.2%
This company
38.2%
Market median
-29% vs market
20202023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202023
Debt / equity
2.67×
This company
0.62×
Market median
-331% vs market
20202023
- Annual report 2023Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SD Liquidator | Liquidator | 2026 |
| Former (2) | ||
MK | Audit | 2016 – 2019 |
AP Audit | Audit | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2017 – 2026 | |
| Chairperson | 2017 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ani Labsystems Ltd. Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mauri Kalevi Eskelinen | Audit | 0 companies |
| Sameer Dungardas Saral | Liquidator | 0 companies |
| Ari Petri Hakkola | Audit | 0 companies |
| Chandra Ganjoo | Board of Directors | 0 companies |
| Kulandaivelu Gomathybabu Sadacharam | Chairperson | 0 companies |